Laboratory reagents for PHC-e
Ended Awarded Last action
- Contract number
- W91YTZ25F0011
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $12,045
Award facts
- Contract value 100% obligated
- $12,045.47 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Meade, MD 20755, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Medical Command awarded a $12,045.47 firm fixed-price blanket purchase agreement call to Roche Diagnostics Corporation for laboratory reagents to support Primary Health Care-East (PHC-E) operations at Fort Meade, Maryland. The contract, awarded on December 27, 2024, with an ultimate completion date of the same day, represents a child delivery order under an existing indefinite delivery vehicle. No set-aside designation was applied to this award, indicating open competition in the federal marketplace. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, specializes in in vitro diagnostics, laboratory instruments, and associated medical products and services.
As a primary supplier of advanced diagnostic capabilities to the Defense Health Agency and other federal healthcare entities, Roche maintains an extensive portfolio of federal contracts for molecular diagnostics, clinical chemistry analysis, immunochemistry testing, and specialized reagents. The company holds multiple active indefinite delivery contracts and blanket purchase agreements across the Department of Veterans Affairs, Defense Health Agency, and other federal agencies, with contract values ranging from under $1,000 to several million dollars and many extending through 2030. This particular call-order award reflects the sustained demand for Roche's diagnostic reagent capabilities to support military healthcare operations.
Quick answers
Who was awarded contract W91YTZ25F0011?
W91YTZ25F0011 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on December 27, 2024.
How much is contract W91YTZ25F0011 worth?
The government has obligated $12,045 on W91YTZ25F0011.
Is contract W91YTZ25F0011 an order under another contract?
Yes. W91YTZ25F0011 is a BPA call under W91YTZ23A0012, a blanket purchase agreement.
Was contract W91YTZ25F0011 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award